Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to…
Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated pathologies, announces the close of a $26 million financing round…
Read More...
Read More...